Document is current
Any future updates will be listed below
-
Authors
Milantoni, Vincent https://orcid.org/0009-0009-2640-009X
Sritharan, Praveen https://orcid.org/0000-0002-2870-5550
Abdel Khalik, Hassaan https://orcid.org/0000-0002-1711-515X
AlKatanani, Fares
Juric, Matey
de SA, Darren https://orcid.org/0000-0002-3997-4078
- License Information
-
More Information
Article History
Accepted: 7 August 2024
First Online: 28 August 2024
Declarations
:
: Dr. de SA is a Pendopharm Regional Working Group and Advisory Board Member and an Advisory Board Member of Heron Therapeutics. He receives consulting fees for Atheneum Partners, Stryker, Brinter, and L.E.K. He receives financial support as a speaker for ConMed Linvatec. His research is supported financially by the Canadian Orthopedic Foundation and Physician Services’ Incorporated Foundation. All of Dr. de SA disclosures are outside of the submitted work.
